Source: International Congress 2016 – Orphan diseases II
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Andrew Creamer (Bristol, United Kingdom), Andrew Creamer, Rezaur Abdullah, Ayesha Jameel, Sam Hare, Rama Vancheeswaran. Factors predicting resolution in nitrofurantoin-induced lung disease. Eur Respir J 2016; 48: Suppl. 60, 3921

Member's Comments

No comment yet.

Related content which might interest you: Statin-induced lung diseases Source: International Congress 2016 – Sarcoidosis Year: 2016 Characterization of emphysema in active farmer’s lung disease Source: International Congress 2016 – Occupational epidemiology Year: 2016 Does CRP predicts severity of hospitalized patients with diffuse interstitial lung disease? Source: International Congress 2014 – ILDs 5 Year: 2014 Clues in interstitial lung disease in children (chILD) Source: International Congress 2016 – Paediatric bronchology II Year: 2016 Correlation of high resolution CT patterns to pulmonary function tests in patients with interstitial lung diseases Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016 Biomarkers for interstitial lung disease Source: International Congress 2016 – ME1 Biomarkers for interstitial lung disease Year: 2016 Imaging in lung disease Source: Eur Respir J 2002; 19: 1S-2S Year: 2002 The prognostic factor in patients with myositis-associated interstitial lung disease Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014 Aetiological panorama in the diagnosis of interstitial lung diseases Source: International Congress 2014 – ILDs 5 Year: 2014 Lung functions and imaging characteristics of the patients with combined pulmonary fibrosis and emphysema Source: International Congress 2015 – IPF: clinical aspects Year: 2015 Markers of injury and fibrosis in occupational interstitial lung diseases (OILD) Source: International Congress 2015 – Occupational disease: clinical cases and series Year: 2015 Does hypoxemia increases risks in hospitalized patients with diffuse interstitial lung disease? Source: International Congress 2014 – ILDs 6 Year: 2014 Early detection of subclinical interstitial lung disease in patients with rheumatoid arthritis and effect of methotrexate therapy Source: International Congress 2014 – ILDs 4 Year: 2014 Chronic hypersensitivity pneumonitis: Is the interstitial pneumonias disease behavior classification suitable for outcome stratification? Source: International Congress 2015 – Interstitial lung diseases II Year: 2015 The role of detection of myositis specific and associated antibodies in Japanese patient with interstitial lung disease Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014 Interstitial lung disease; where do we stand without histopathology? Source: Annual Congress 2013 –Diffuse parenchymal lung disease II Year: 2013 Annual changes in pulmonary function are independent prognostic factors for the patients with chronic hypersensitivity pneumonia Source: International Congress 2014 – ILDs 3 Year: 2014 Childhood diffuse parenchymal lung diseases: Diagnosis, treatment and outcome Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013